Kroger Recalls Ondansetron Tablets Due to Lack of Processing Controls
Kroger Specialty Pharmacy is recalling one lot of Ondansetron 8 mg tablets because the product lacked required processing controls.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is FDA Class II due to a lack of processing controls, which poses a risk of harm where injury has not yet been reported. According to the rubric, this falls under 'risk-of-harm products where injury has not yet been reported,' warranting a High severity score.
Plain-English summary
Kroger Specialty Pharmacy, Inc. is voluntarily recalling one lot of Ondansetron 8 mg tablets (NDC 57237-0076-30) distributed in Mississippi, Louisiana, Arkansas, Illinois, and Florida. The recall covers a 28-day supply dispensed between December 1, 2017, and February 12, 2018.
The FDA classified this recall as Class II. The reason for the recall is a lack of processing controls during manufacturing. This defect could potentially affect the safety or efficacy of the medication, although no illnesses have been reported.
Consumers who may have received this product should contact Kroger Specialty Pharmacy to return the medication. Healthcare providers and patients are advised to check lot numbers against the recall notice.
The recalled product
- Product
- Ondansetron 8 mg tablet NDC 57237-0076-30 28 days supply
- Manufacturer
- Kroger Specialty Pharmacy, Inc.
- Category
- Drug — Ondansetron 8 mg tablet
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
Distribution
Part of a larger recall action
This product is one of 67 recalled by Kroger Specialty Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same manufacturer · Kroger Specialty Pharmacy, Inc.
See all →- HighKroger Recalls Botox Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Capecitabine Tablets Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cimzia 200 mg/mL PFS Kits
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Lupron Depot Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cyclophosphamide Capsules Due to Processing Controls
FDA (Drugs) · 2018-05-16
Same hazard · lack of processing controls
See all →- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Yohimbine HCL Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05